Ursodeoxycholic acid or ursodiol
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171962This classification denotes a protein kinase c inhibitor and anti-lipidemic agent with the molecular formula C24H40O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 724L30Y2QR, chemically known as cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.beta.)- but more generally known as ursodeoxycholic acid, which bears US NIH Compound Identifier 5645. European Medicines Agency schedules Ursodeoxycholic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11389MIG. The term URSODEOXYCHOLIC ACID is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules ursodeoxycholic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Ursodiol bears US NLM identifiers UMLS ID C0042105 and NCI Concept Code C1818. SMILES: OC1C2C3C(C(CC3)C(CCC(=O)O)C)(CCC2C2(C(C1)CC(O)CC2)C)C.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.